08/12/2017 01:09:50

ZYTO Partners with Keiser University & China Functional Medicine Institute to Expand Health Research

LINDON, Utah, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Last month, ZYTO (OTC PINK:ZYTO) executed a letter of intent together with Keiser University and the China Functional Medicine Institute to cooperate in biocommunication research, academics, and clinical integration. This document was executed at a ceremony in Shanghai, China, by Dr. Vaughn R Cook, CEO of ZYTO, Gavin Chen, Dean of Academic Affairs, Keiser University – Shanghai Off-Campus Site, and Dr. Shaoqing Li, Director for the China Functional Medicine Institute.

A photo accompanying this announcement is available at:

http://www.globenewswire.com/NewsRoom/AttachmentNg/d7e642e7-6787-474f-b8b3-2d9ca3687a01

Dr. Cook was given by Keiser University the title of Visiting Professor and Director of Keiser Shanghai Big Data Driven Lab for Human Health, and appointed as a Distinguished Professor by the China Functional Medicine Institute.

“It’s a great honor to be associated with institutions and organizations with the stature of Keiser University and the China Functional Medicine Institute,” said Dr. Cook. “This begins the launch of significant contributions by all parties to the health and well-being of the Chinese people. We’re pleased to be part of this consortium and are committed to the pursuit of our common objectives.”

ZYTO will assist the Keiser University Off-Campus site in Shanghai with its Big Data Program, which was officially approved by the China Ministry of Education earlier this year. The university has set up a base lab at their Shanghai campus for the Big Data Program to foster connections between its students and local healthcare and other industries.

About Keiser University

Keiser University, co-founded by Dr. Arthur Keiser, Chancellor in 1977, is a private, not-for-profit University serving nearly 20,000 students offering 100 degrees at the doctoral through associate level on 19 Florida campuses, online and internationally, employing 3,800 staff and faculty.

Ranked #52 out of 149 prestigious universities by U.S. News & World Report in its 2018 Best Regional Universities South category, Keiser University is accredited by the Southern Association of Colleges and Schools Commission on Colleges to award certificates and degrees at the associate, baccalaureate, masters, specialist, and doctoral levels.

The Keiser University Shanghai Off-Campus Site has been operating in China for more than 5 years and continues to expand its presence there.

About the China Functional Medicine Institute

The China Functional Medicine Institute is organized to bring functional medicine to China and to train doctors in the principles and practices of functional medicine. Shaoqing Li, MD, a Chinese and functional medicine pioneer and advocate, directs the institute. Dr. Li is also the founder of the Center of Anti-Aging and Dean of the Chinese Academy of Functional Medicine.

About ZYTO

ZYTO is a technology company founded in 2004 by Dr. Vaughn R Cook. The company provides biocommunication hardware and software with wellness and lifestyle applications that include obtaining and analyzing galvanic skin response data from the human body to assist in making better decisions.

Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO’s marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO’s stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company’s products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.

Contact Information

Any questions regarding this release can be directed to:

Adam Ford

ZYTO Corporation General Counsel

aford@ZYTO.com

www.ZYTO.com

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Jan
OMXC25
@ Poppelkongen: Jeg tror ski da, at du har misforstået brugen af filteret?! Når du nævner, at du er..
35
17 Jan
 
Hej alle,   Nu hvor jeg tager et sabat-år som investor i 2018, tænkte jeg, at jeg ville lave en upda..
26
11:35
 
Jeg har på en fornemmelsen at i ikke bryder jer om mig? Ik sandt? Så har overvejet at stoppe på EI. ..
19
15 Jan
BEO-SDB
Godmorgen,   Som langt størstedelen af jer der har investeret i BEO ved, afventer vi svar fra Bergst..
18
15 Jan
VWS
Vi har snakker Vestas Service en gang i dag, men jeg tror, at selv Vestas Group er overrasket over, ..
16
11:41
 
Måske du bare skulle revurdere din adfærd og generelle ageren?
15
18 Jan
VWS
Utroligt, at det nu i flere år har været muligt og lovligt at handle under dæknavnet "Anonymous Brok..
15
18 Jan
VWS
Mere utroligt så vildt hurtige folk er til at hoppe på alle mulige konspirationsteorier hvis ikke ku..
14
14 Jan
YY
Fordi vi ikke er friske på en ret ukendt lille kinesisk aktie, så er vi ikke idioter ..... men tilly..
13
07:19
NOVO-B
Novo/Goldman: Kursmålet hæves med godt 30 pct. 19/1/2018 06.34· Ritzau Finans Den danske medicinalgi..
12

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

19/01/2018 15:28:15
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Invesco Ltd. : Form 8.3 - Informa Plc

19/01/2018 13:58:51
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Invesco Ltd. (b) Owner or control..

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

19/01/2018 10:18:53
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Bavarian Nordic Announces Initiation of Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis
2
Olympus Labs Partners with Leading Korean Fintech Company Metaps Plus
3
Bavarian Nordic Announces Initiation of Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis
4
Forward Industries Acquires Intelligent Product Solutions
5
Panera Bread Petitions FDA to Clearly Define “Egg” in Effort to Improve Industry Standards for Food Transparency

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 January 2018 21:27:21
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180112.1 - EUROWEB5 - 2018-01-19 22:27:21 - 2018-01-19 21:27:21 - 1000 - Website: OKAY